欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号FR/V/0182/001
药品名称POULVAC PABAC IV
活性成分
    • pasteurella multocida 70.0 %survival X73
    • pasteurella multocida 70.0 %survivalP1059
    • pasteurella multocida 70.0 %survivalP1662
    • pasteurella multocida 70.0 %survivalCU
剂型Emulsion for injection
上市许可持有人PFIZER
参考成员国 - 产品名称France (FR)
POULVAC PABAC IV
互认成员国 - 产品名称
    • Iceland (IS)
    • Greece (GR)
    • Finland (FI)
    • Cyprus (CY)
    • Malta (MT)
    • Norway (NO)
    • Germany (DE)
    • Denmark (DK)
      POULVAC PABAC IV
    • Belgium (BE)
    • Luxembourg (LU)
    • Portugal (PT)
    • Italy (IT)
    • Poland (PL)
    • Latvia (LV)
    • Hungary (HU)
      Poulvac Pabac IV vakcina A.U.V.
    • Bulgaria (BG)
      Poulvac Pabac IV
    • Czechia (CZ)
    • Romania (RO)
    • Slovakia (SK)
    • Slovenia (SI)
      POULVAC PABAC IV emulzija za injiciranje
许可日期2007/05/23
最近更新日期2025/03/25
药物ATC编码
    • QI01AB02 pasteurella
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：Full dossier - art 12.3 Dir 2001/82/EC
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase